Polygenic liability, stressful life events and risk for secondary-treated depression in early life: a nationwide register-based case-cohort study.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
01 2023
Historique:
medline: 4 5 2023
pubmed: 6 5 2021
entrez: 5 5 2021
Statut: ppublish

Résumé

In this study, we examined the relationship between polygenic liability for depression and number of stressful life events (SLEs) as risk factors for early-onset depression treated in inpatient, outpatient or emergency room settings at psychiatric hospitals in Denmark. Data were drawn from the iPSYCH2012 case-cohort sample, a population-based sample of individuals born in Denmark between 1981 and 2005. The sample included 18 532 individuals who were diagnosed with depression by a psychiatrist by age 31 years, and a comparison group of 20 184 individuals. Information on SLEs was obtained from nationwide registers and operationalized as a time-varying count variable. Hazard ratios and cumulative incidence rates were estimated using Cox regressions. Risk for depression increased by 35% with each standard deviation increase in polygenic liability ( These findings suggest that although there is minimal interaction between polygenic liability and SLEs as risk factors for hospital-treated depression, combining information on these two important risk factors could potentially be useful for identifying high-risk individuals.

Sections du résumé

BACKGROUND
In this study, we examined the relationship between polygenic liability for depression and number of stressful life events (SLEs) as risk factors for early-onset depression treated in inpatient, outpatient or emergency room settings at psychiatric hospitals in Denmark.
METHODS
Data were drawn from the iPSYCH2012 case-cohort sample, a population-based sample of individuals born in Denmark between 1981 and 2005. The sample included 18 532 individuals who were diagnosed with depression by a psychiatrist by age 31 years, and a comparison group of 20 184 individuals. Information on SLEs was obtained from nationwide registers and operationalized as a time-varying count variable. Hazard ratios and cumulative incidence rates were estimated using Cox regressions.
RESULTS
Risk for depression increased by 35% with each standard deviation increase in polygenic liability (
CONCLUSIONS
These findings suggest that although there is minimal interaction between polygenic liability and SLEs as risk factors for hospital-treated depression, combining information on these two important risk factors could potentially be useful for identifying high-risk individuals.

Identifiants

pubmed: 33949298
doi: 10.1017/S0033291721001410
pii: S0033291721001410
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-226

Auteurs

Katherine L Musliner (KL)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.

Klaus K Andersen (KK)

Unit for Statistics and Pharmacoepidemiology (SPE), Danish Cancer Society Research Center (DCRC), Copenhagen, Denmark.

Esben Agerbo (E)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.
The Center for Integrated Register-based Research at Aarhus University (CIRRAU), Aarhus, Denmark.

Clara Albiñana (C)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.

Bjarni J Vilhjalmsson (BJ)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.
Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark.

Veera M Rajagopal (VM)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
Center for Genome Analysis and Personalized Medicine, Aarhus, Denmark.

Jonas Bybjerg-Grauholm (J)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Department for Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark.

Marie Bækved-Hansen (M)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Department for Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark.

Carsten B Pedersen (CB)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.
The Center for Integrated Register-based Research at Aarhus University (CIRRAU), Aarhus, Denmark.

Marianne G Pedersen (MG)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.
The Center for Integrated Register-based Research at Aarhus University (CIRRAU), Aarhus, Denmark.

Trine Munk-Olsen (T)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.

Michael E Benros (ME)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.

Thomas D Als (TD)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Jakob Grove (J)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Genome Analysis and Personalized Medicine, Aarhus, Denmark.

Thomas Werge (T)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Institute of Biological Psychiatry, Copenhagen Mental Health Services, Copenhagen, Denmark.

Anders D Børglum (AD)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.

David M Hougaard (DM)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Department for Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark.

Ole Mors (O)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.

Merete Nordentoft (M)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.

Preben B Mortensen (PB)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
National Center for Register-based Research, Department of Economics, Aarhus University, Aarhus, Denmark.
The Center for Integrated Register-based Research at Aarhus University (CIRRAU), Aarhus, Denmark.

Nis P Suppli (NP)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark.
Mental Health Center Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH